141 related articles for article (PubMed ID: 33738076)
1. Structure-based Discovery of Cell-Potent Peptidomimetic Inhibitors for Protein N-Terminal Methyltransferase 1.
Chen D; Dong G; Deng Y; Noinaj N; Huang R
ACS Med Chem Lett; 2021 Mar; 12(3):485-493. PubMed ID: 33738076
[TBL] [Abstract][Full Text] [Related]
2. Selective Peptidomimetic Inhibitors of NTMT1/2: Rational Design, Synthesis, Characterization, and Crystallographic Studies.
Mackie BD; Chen D; Dong G; Dong C; Parker H; Schaner Tooley CE; Noinaj N; Min J; Huang R
J Med Chem; 2020 Sep; 63(17):9512-9522. PubMed ID: 32689795
[TBL] [Abstract][Full Text] [Related]
3. Improved Cell-Potent and Selective Peptidomimetic Inhibitors of Protein N-Terminal Methyltransferase 1.
Dong G; Iyamu ID; Vilseck JZ; Chen D; Huang R
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209173
[TBL] [Abstract][Full Text] [Related]
4. Design and characterization of PROTAC degraders specific to protein N-terminal methyltransferase 1.
Zhou Q; Wu W; Jia K; Qi G; Sun XS; Li P
Eur J Med Chem; 2022 Dec; 244():114830. PubMed ID: 36228414
[TBL] [Abstract][Full Text] [Related]
5. Venglustat Inhibits Protein N-Terminal Methyltransferase 1 in a Substrate-Competitive Manner.
Dong G; Deng Y; Yasgar A; Yadav R; Talley D; Zakharov AV; Jain S; Rai G; Noinaj N; Simeonov A; Huang R
J Med Chem; 2022 Sep; 65(18):12334-12345. PubMed ID: 36074125
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and kinetic analysis of potent protein N-terminal methyltransferase 1 inhibitors.
Zhang G; Richardson SL; Mao Y; Huang R
Org Biomol Chem; 2015 Apr; 13(14):4149-54. PubMed ID: 25712161
[TBL] [Abstract][Full Text] [Related]
7. Discovery of Bisubstrate Inhibitors for Protein N-Terminal Methyltransferase 1.
Chen D; Dong G; Noinaj N; Huang R
J Med Chem; 2019 Apr; 62(7):3773-3779. PubMed ID: 30883119
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for substrate recognition by the human N-terminal methyltransferase 1.
Dong C; Mao Y; Tempel W; Qin S; Li L; Loppnau P; Huang R; Min J
Genes Dev; 2015 Nov; 29(22):2343-8. PubMed ID: 26543161
[TBL] [Abstract][Full Text] [Related]
9. Probing the Plasticity in the Active Site of Protein N-terminal Methyltransferase 1 Using Bisubstrate Analogues.
Chen D; Dong C; Dong G; Srinivasan K; Min J; Noinaj N; Huang R
J Med Chem; 2020 Aug; 63(15):8419-8431. PubMed ID: 32605369
[TBL] [Abstract][Full Text] [Related]
10. Structure-Activity Relationship Studies of Venglustat on NTMT1 Inhibition.
Deng Y; Dong G; Meng Y; Noinaj N; Huang R
J Med Chem; 2023 Jan; 66(2):1601-1615. PubMed ID: 36634151
[TBL] [Abstract][Full Text] [Related]
11. Kinetic mechanism of protein N-terminal methyltransferase 1.
Richardson SL; Mao Y; Zhang G; Hanjra P; Peterson DL; Huang R
J Biol Chem; 2015 May; 290(18):11601-10. PubMed ID: 25771539
[TBL] [Abstract][Full Text] [Related]
12. Chemoproteomic Study Uncovers HemK2/KMT9 As a New Target for NTMT1 Bisubstrate Inhibitors.
Chen D; Meng Y; Yu D; Noinaj N; Cheng X; Huang R
ACS Chem Biol; 2021 Jul; 16(7):1234-1242. PubMed ID: 34192867
[TBL] [Abstract][Full Text] [Related]
13.
Jia K; Huang G; Wu W; Shrestha R; Wu B; Xiong Y; Li P
Chem Sci; 2019 Sep; 10(35):8094-8099. PubMed ID: 31857877
[TBL] [Abstract][Full Text] [Related]
14. NRMT is an alpha-N-methyltransferase that methylates RCC1 and retinoblastoma protein.
Tooley CE; Petkowski JJ; Muratore-Schroeder TL; Balsbaugh JL; Shabanowitz J; Sabat M; Minor W; Hunt DF; Macara IG
Nature; 2010 Aug; 466(7310):1125-8. PubMed ID: 20668449
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
[TBL] [Abstract][Full Text] [Related]
16. Discovering the N-Terminal Methylome by Repurposing of Proteomic Datasets.
Chen P; Paschoal Sobreira TJ; Hall MC; Hazbun TR
J Proteome Res; 2021 Sep; 20(9):4231-4247. PubMed ID: 34382793
[TBL] [Abstract][Full Text] [Related]
17. Modulation of N-terminal methyltransferase 1 by an N
Bade D; Cai Q; Li L; Yu K; Dai X; Miao W; Wang Y
Biochem Biophys Res Commun; 2021 Mar; 546():54-58. PubMed ID: 33561748
[TBL] [Abstract][Full Text] [Related]
18. An asparagine/glycine switch governs product specificity of human N-terminal methyltransferase NTMT2.
Dong C; Dong G; Li L; Zhu L; Tempel W; Liu Y; Huang R; Min J
Commun Biol; 2018; 1():183. PubMed ID: 30417120
[TBL] [Abstract][Full Text] [Related]
19. Selective peptidic and peptidomimetic inhibitors of Candida albicans myristoylCoA: protein N-myristoyltransferase: a new approach to antifungal therapy.
Sikorski JA; Devadas B; Zupec ME; Freeman SK; Brown DL; Lu HF; Nagarajan S; Mehta PP; Wade AC; Kishore NS; Bryant ML; Getman DP; McWherter CA; Gordon JI
Biopolymers; 1997; 43(1):43-71. PubMed ID: 9174411
[TBL] [Abstract][Full Text] [Related]
20. Lead discovery, chemical optimization, and biological evaluation studies of novel histone methyltransferase SET7 small-molecule inhibitors.
Hou Z; Min W; Zhang R; Niu A; Li Y; Cao L; Han J; Luo C; Yang P; Ding H
Bioorg Med Chem Lett; 2020 May; 30(9):127061. PubMed ID: 32173197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
